Our goal is to commercialize affordable, safe, and convenient NASH diagnosis and tracking.
In 2017, a group of cross-disciplinary Virginia Tech students from the colleges of engineering, business, and medicine designed and pitched a medical start-up at the first-ever VTCRI Biomedical Competition. Early the following year, out of over 100 applicants, the students became top 12 finalists at the VT Entrepreneur Challenge, ultimately placing in the top 5 and winning $5,000. To commercialize the technology and keep the team together, "Aecium Medical Solutions" was founded shortly thereafter.
Aecium was selected to compete at the American Evolution Innovators Cup where 14 of the best teams from universities across the commonwealth of Virginia travel to Charlottesville to pitch their startup at the Tom Tom Founders Festival. The team finished in first place, winning $10,000 and the opportunity to pitch to angel investors at The Galant Challenge.
We have since rebranded to Vixi Biotech and have been working to achieve a number of milestones while remaining committed to our mission statement of commercializing non-invasive NASH diagnosis to make it affordable, safe, and convenient.
Founder & Director
Glenn has over 8 years of experience leading organizations in both the for-profit and nonprofit sectors. He comes to Vixi with a diverse business and technical professional background in the information technology, aviation, energy, finance, and medical industries. Prior to Vixi, Glenn launched two successful technology-oriented startups. In addition to pursuing a B.S. in Entrepreneurship, Innovation, and Technology Management, Glenn is president of Entrepreneurship Club at Virginia Tech.
Founder & Technology Developer
Ben holds a B.S. in Engineering Science and Mechanics, and is pursuing a M.S. in Engineering Mechanics. Ben has experience as a research engineer for the Virginia Tech college of Engineering, where he conducted extensive analysis of data on experiments involving new biomedical technology. As the Technology Developer, Ben oversees Vixi's clinical studies, data collection, and analysis efforts.
Brett Malone, Ph.D.
Commercialization Expert & Advisor
Brett is a senior biomedical executive with commercial experience in opening new markets and generating business for innovative products and technologies. He has 20 years of experience in therapeutics, diagnostics, devices, synthetic biology, biomarkers, and novel platforms. Specifically, Brett was Chief Commercial Officer for a liver diagnostics company and was involved in creating partnerships with Gilead, Intercept, and other major pharma companies. He has been instrumental in developing Vixi's commercialization strategy and plan to secure industry partnerships.
Ancha Baranova, Ph.D.
Scientific Advisor & Lead Inventor
Dr. Baranova is an associate professor in the School of Systems Biology at George Mason University. Dr. Baranova runs both experimental and computational research programs in the highly interdisciplinary and collaborative field of personalized medicine. She is an expert in systems biology driven analysis of the human metabolism, with an emphasis on diseases associated with the process of ageing. She is an author of more than 150 research papers, reviews, and opinion pieces in the field of human systems biology.